CancerLinQ™ Platform Hits Milestone of Having More Than 1 Million Patient Records in System

Seventy Practices Have Signed Agreements to Participate

Get Permission

CancerLinQ LLC, a wholly owned nonprofit of ASCO, announced on October 20, 2016, that more than 1 million patient records are now in the CancerLinQ™ platform. In addition, 70 practices have signed agreements to participate in CancerLinQ, representing more than 1,500 oncologists.

“We are excited to reach this milestone and continue to be awed and inspired by the engagement and support from the oncology community,” said CancerLinQ LLC CEO Kevin Fitzpatrick. “As more records enter the CancerLinQ platform, it will enhance participating oncologists’ ability to improve the quality of care that they provide.”

Real-World Cancer Information

CancerLinQ™ is a powerful platform containing growing amounts of real-world cancer information. This national initiative will allow cancer providers to improve the quality and value of care by analyzing millions of cancer patient medical records, uncovering patterns and trends, and measuring their care against that of their peers and recommended guidelines.

The CLQ platform was codeveloped with SAP utilizing the SAP Connected Health platform that runs on SAP HANA, a flexible, in-memory data management and application platform created by SAP.

CancerLinQ LLC has completed agreements with 70 oncology practices in 39 states and the District of Columbia, and is potentially available to any practice nationwide. Participants range from small private practices to some of the nation’s leading cancer centers. CancerLinQ has also successfully connected with most major electronic health records systems, including both enterprise and oncology-specific systems, showing data can be shared seamlessly and securely across technical platforms. To view the list of practices participating in CancerLinQ™, please go to ■




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.